The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 31, 2019
Filed:
Aug. 24, 2015
Applicant:
Guangzhou Virotech Pharmaceutical Co., Ltd., Guangzhou, Guandong, CN;
Inventors:
Guangmei Yan, Guangzhou, CN;
Xiao Xiao, Guangzhou, CN;
Jun Hu, Guangzhou, CN;
Kai Li, Guangzhou, CN;
Jiankai Liang, Guangzhou, CN;
Yuan Lin, Guangzhou, CN;
Haipeng Zhang, Guangzhou, CN;
Suizhen Lin, Guangzhou, CN;
Assignee:
GUANGZHOU VIROTECH PHARMACEUTICAL CO., LTD, Guangzhou, Guandong, CN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 39/00 (2006.01); A61K 39/095 (2006.01); C12N 15/86 (2006.01); C07H 21/04 (2006.01); A61K 35/768 (2015.01); C12N 7/00 (2006.01); C12N 15/113 (2010.01);
U.S. Cl.
CPC ...
A61K 35/768 (2013.01); C12N 7/00 (2013.01); C12N 15/1138 (2013.01); C12N 2310/14 (2013.01); C12N 2320/31 (2013.01); C12N 2770/36132 (2013.01);
Abstract
Disclosed is use of alphavirus in preparation of antitumor drugs. The alphavirus is M1 virus or Getah virus. In addition, the specific tumor types sensitive to abovementioned alphavirus treatment are further determined, so as to provide a safe and effective solution for antitumor drug administering schemes.